Twist Bioscience Corp TWST
News
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Twist Bioscience to Present at Upcoming Investor Conferences
Notice of Proposed Derivative Settlement: Twist Bioscience Corporation
Twist Bioscience Launches MRD Express with Rapid Turnaround Time
Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies
Twist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
Twist Biosciences Shares Rise on Deal With Eli Lilly's TuneLab
Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

